Literature DB >> 8477753

Natural cycloheximide resistance in yeast. The role of ribosomal protein L41.

P Dehoux1, J Davies, M Cannon.   

Abstract

The yeast Kluyveromyces lactis is resistant to high concentrations (1 mg/ml) of the antibiotic cycloheximide. Using in vitro translation studies it was confirmed that this extreme resistance is a property of ribosomes. The resistance determinant from K. lactis was cloned into Saccharomyces cerevisiae. Nucleotide sequence analysis of the determinant demonstrated that resistance was conferred by the K. lactis ribosomal protein L41. K. lactis was shown to contain only one copy of the gene that encodes this protein and the gene was located to chromosome III. In contrast, S. cerevisiae was found to contain multiple copies of the gene for the corresponding ribosomal protein L41 which mapped to two of the three chromosomes V, XIV and VIII. Since the cycloheximide-resistance gene of K. lactis causes essentially complete protection against inhibition by the drug, it is likely to be particularly useful as a selective marker in eukaryotic gene transfer studies.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8477753     DOI: 10.1111/j.1432-1033.1993.tb17827.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  15 in total

1.  Cloning of the ribosomal protein L41 gene of Phaffia rhodozyma and its use a drug resistance marker for transformation.

Authors:  I G Kim; S K Nam; J H Sohn; S K Rhee; G H AN; S H Lee; E S Choi
Journal:  Appl Environ Microbiol       Date:  1998-05       Impact factor: 4.792

2.  Isolation, heterological cloning and sequencing of the RPL28 gene in Kluyveromyces lactis.

Authors:  Maria Takacova; Peter Sklenar; Yvetta Gbelska; Karin Breunig; Julius Subik
Journal:  Curr Genet       Date:  2002-09-27       Impact factor: 3.886

3.  Highly diverged homologs of Saccharomyces cerevisiae mitochondrial mRNA-specific translational activators have orthologous functions in other budding yeasts.

Authors:  M C Costanzo; N Bonnefoy; E H Williams; G D Clark-Walker; T D Fox
Journal:  Genetics       Date:  2000-03       Impact factor: 4.562

4.  Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene.

Authors:  R Ben-Yaacov; S Knoller; G A Caldwell; J M Becker; Y Koltin
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

5.  Integrative transformation system for the metabolic engineering of the sphingoid base-producing yeast Pichia ciferrii.

Authors:  Jung-Hoon Bae; Jung-Hoon Sohn; Chang-Seo Park; Joon-Shick Rhee; Eui-Sung Choi
Journal:  Appl Environ Microbiol       Date:  2003-02       Impact factor: 4.792

6.  A transformation system for the yeast Candida utilis: use of a modified endogenous ribosomal protein gene as a drug-resistant marker and ribosomal DNA as an integration target for vector DNA.

Authors:  K Kondo; T Saito; S Kajiwara; M Takagi; N Misawa
Journal:  J Bacteriol       Date:  1995-12       Impact factor: 3.490

7.  Multidrug resistance in Candida albicans: disruption of the BENr gene.

Authors:  M Goldway; D Teff; R Schmidt; A B Oppenheim; Y Koltin
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

8.  Evolution of Substrates and Components of the Pro/N-Degron Pathway.

Authors:  Shun-Jia Chen; Artem Melnykov; Alexander Varshavsky
Journal:  Biochemistry       Date:  2020-01-02       Impact factor: 3.162

9.  Structural basis for the inhibition of the eukaryotic ribosome.

Authors:  Nicolas Garreau de Loubresse; Irina Prokhorova; Wolf Holtkamp; Marina V Rodnina; Gulnara Yusupova; Marat Yusupov
Journal:  Nature       Date:  2014-09-10       Impact factor: 49.962

10.  Antifungal Efficacy and Safety of Cycloheximide as a Supplement in Optisol-GS.

Authors:  Melissa Dal Pizzol; Eduarda Correa Freitas; Claudete Locatelli; Felipe Guareze; Paula Reginatto; Gabriella Machado; Alexandre Fuentefria; Diane Marinho
Journal:  Drug Des Devel Ther       Date:  2021-05-18       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.